130 related articles for article (PubMed ID: 22317767)
1. Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma.
Chu H; Wang M; Yan F; Zhong D; Shi D; Ma L; Pan X; Qin C; Yin C; Zhang Z
Ann Oncol; 2012 Aug; 23(8):2114-2121. PubMed ID: 22317767
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population.
Lin Y; Yuan Q; Qian F; Qin C; Cao Q; Wang M; Chu H; Zhang Z
Gene; 2019 Feb; 685():242-247. PubMed ID: 30472377
[TBL] [Abstract][Full Text] [Related]
3. The polymorphisms of IL-4, IL-4R and IL-13 genes and bladder cancer risk in a Chinese population: a case-control study.
Chu H; Ma L; Wang M; Shi D; Qin C; Yuan L; Yin C; Zhang Z
Mol Biol Rep; 2012 May; 39(5):5349-57. PubMed ID: 22170601
[TBL] [Abstract][Full Text] [Related]
4. Associations of IL-4, IL-4R, and IL-13 gene polymorphisms in coal workers' pneumoconiosis in China: a case-control study.
Wang M; Wang S; Song Z; Ji X; Zhang Z; Zhou J; Ni C
PLoS One; 2011; 6(8):e22624. PubMed ID: 21857939
[TBL] [Abstract][Full Text] [Related]
5. IL-16 polymorphism and risk of renal cell carcinoma: association in a Chinese population.
Zhu J; Qin C; Yan F; Wang M; Ding Q; Zhang Z; Yin C
Int J Urol; 2010 Aug; 17(8):700-7. PubMed ID: 20529140
[TBL] [Abstract][Full Text] [Related]
6. Association of IL-4 -590 T>C polymorphism and risk of renal cell carcinoma in a Chinese population.
Zhu J; Ju X; Yan F; Qin C; Wang M; Ding Q; Zhang Z; Yin C
Int J Immunogenet; 2010 Dec; 37(6):459-65. PubMed ID: 20618516
[TBL] [Abstract][Full Text] [Related]
7. Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.
Liu GX; Zhang X; Li S; Koiiche RD; Sindsceii JH; Song H
Tumour Biol; 2013 Oct; 34(5):2741-6. PubMed ID: 23657965
[TBL] [Abstract][Full Text] [Related]
8. The Role of IL-10 Promoter Polymorphisms in Renal Cell Carcinoma.
Chang WS; Liao CH; Tsai CW; Hu PS; Wu HC; Hsu SW; Ji HX; Hsiao CL; Bau DT
Anticancer Res; 2016 May; 36(5):2205-9. PubMed ID: 27127124
[TBL] [Abstract][Full Text] [Related]
9. GNAS1 (Gαs) gene T393C polymorphism and renal cell carcinoma risk in a North Indian population: a case-control study.
Arjumand W; Ahmad ST; Nafees S; Ali N; Rashid S; Seth A; Sultana S
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1062-6. PubMed ID: 22931242
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population.
Nakamura E; Megumi Y; Kobayashi T; Kamoto T; Ishitoya S; Terachi T; Tachibana M; Matsushiro H; Habuchi T; Kakehi Y; Ogawa O
Clin Cancer Res; 2002 Aug; 8(8):2620-5. PubMed ID: 12171893
[TBL] [Abstract][Full Text] [Related]
11. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-16 rs4778889 polymorphism contributes to the development of renal cell cancer in a Chinese population.
Wang Z; Xu Y; Zhu S
Int J Clin Exp Pathol; 2015; 8(11):15228-33. PubMed ID: 26823871
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Inflammatory Cytokine Interleukin-18 Genotypes to Renal Cell Carcinoma.
Chang WS; Shen TC; Yeh WL; Yu CC; Lin HY; Wu HC; Tsai CW; Bau DT
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925760
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis.
Ferreira M; Teixeira A; Maurício J; Lobo F; Morais A; Medeiros R
Urol Oncol; 2017 Aug; 35(8):532.e25-532.e30. PubMed ID: 28476527
[TBL] [Abstract][Full Text] [Related]
15. Impact of Vascular Endothelial Growth Factor Gene Polymorphisms and Their Interactions with Environmental Factors on Susceptibility to Renal Cell Carcinoma.
Liu F; Wen T; Tang Q; Chen F; Liao D
Nephron; 2020; 144(5):255-260. PubMed ID: 32182617
[TBL] [Abstract][Full Text] [Related]
16. Association of hypoxia-inducible factor-1 alpha gene polymorphism with renal cell carcinoma susceptibility.
Huang L; Li MQ; Ou C; Huang WC; Liu JF; Huang H
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1105-S1109. PubMed ID: 30539853
[TBL] [Abstract][Full Text] [Related]
17. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma risk is associated with the interactions of APOE, VHL and MTHFR gene polymorphisms.
Lv C; Bai Z; Liu Z; Luo P; Zhang J
Int J Clin Exp Pathol; 2015; 8(5):5781-6. PubMed ID: 26191297
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas.
Xian W; Zheng H; Wu WJ
Genet Mol Res; 2015 Jul; 14(3):7634-42. PubMed ID: 26214443
[TBL] [Abstract][Full Text] [Related]
20. Association of caveolin-1 genotypes with renal cell carcinoma risk in Taiwan.
Chang WS; Tsai CW; Wang SM; Wang SW; Wu HC; Ji HX; Lin CH; Wang ZH; Chou JC; Bau DT; Wang PS
Chin J Physiol; 2014 Aug; 57(4):220-6. PubMed ID: 25246063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
